Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Annalisa Ciabattini"'
Autor:
Gabiria Pastore, Jacopo Polvere, Fabio Fiorino, Simone Lucchesi, Giorgio Montesi, Ilaria Rancan, Sara Zirpoli, Arianna Lippi, Miriam Durante, Massimiliano Fabbiani, Mario Tumbarello, Francesca Montagnani, Donata Medaglini, Annalisa Ciabattini
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 432-444 (2024)
ABSTRACTBackground Heterologous prime-boost schedules have been employed in SARS-CoV-2 vaccination, yet additional data on immunogenicity and effectiveness are still needed.Research design and methods Here, we measured the immunogenicity and effectiv
Externí odkaz:
https://doaj.org/article/57414c1aeb95453cac2578ec49079d8f
Autor:
Giorgio Montesi, Matteo Augello, Jacopo Polvere, Giulia Marchetti, Donata Medaglini, Annalisa Ciabattini
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background SARS-CoV-2 mRNA vaccines are highly immunogenic in people living with HIV (PLWH) on effective antiretroviral therapy (ART). However, whether viro-immunologic parameters or other factors affect immune responses to vaccination is de
Externí odkaz:
https://doaj.org/article/c21d1f747bd24dbcb199316b12825903
Autor:
Eleonora Vianello, Josefine Persson, Björn Andersson, Suzanne van Veen, Thomaz Lüscher Dias, Francesco Santoro, Malin Östensson, Ogonna Obudulu, Christopher Agbajogu, Sara Torkzadeh, Helder I. Nakaya, Donata Medaglini, Claire-Anne Siegrist, Tom H.M. Ottenhoff, Ali M. Harandi, Selidji Todagbe Agnandji, Rafi Ahmed, Jenna Anderson, Floriane Auderset, Philip Bejon, Luisa Borgianni, Jessica Brosnahan, Annalisa Ciabattini, Olivier Engler, Marielle C. Haks, Donald Gray Heppner, Alice Gerlini, Angela Huttner, Peter G. Kremsner, Thomas Monath, Francis Ndungu, Patricia Njuguna, David Pejoski, Mark Page, Gianni Pozzi, Sheri Dubey, Micheal J. Eichberg, Patrícia Gonzalez-Dias, Paulin Ndong Essone, Lumeka Kabwende, Peter Gottfried Kremsner, Helder Nakaya, Sravya S. Nakka, Mariëlle C. Haks, Sylvia Rothenberger
Publikováno v:
iScience, Vol 26, Iss 12, Pp 108574- (2023)
Summary: The vectored Ebola vaccine rVSVΔG-ZEBOV-GP elicits protection against Ebola Virus Disease (EVD). In a study of forty-eight healthy adult volunteers who received either the rVSVΔG-ZEBOV-GP vaccine or placebo, we profiled intracellular micro
Externí odkaz:
https://doaj.org/article/d1e7ad08e3484b79982a9a85a16c47ce
Autor:
Elena Pettini, Annalisa Ciabattini, Fabio Fiorino, Jacopo Polvere, Gabiria Pastore, Monica Tozzi, Francesca Montagnani, Giuseppe Marotta, Alessandro Bucalossi, Donata Medaglini
Publikováno v:
Vaccines, Vol 12, Iss 4, p 368 (2024)
Preventing SARS-CoV-2 infection is of utmost importance in allogeneic hematopoietic cell transplantation patients (allo-HCT), given their heightened susceptibility to adverse outcomes associated with SARS-CoV-2 infection. However, limited data are av
Externí odkaz:
https://doaj.org/article/52aba8097874413bb41ba03c7ae8f864
Autor:
Jacopo Polvere, Massimiliano Fabbiani, Gabiria Pastore, Ilaria Rancan, Barbara Rossetti, Miriam Durante, Sara Zirpoli, Enrico Morelli, Elena Pettini, Simone Lucchesi, Fabio Fiorino, Mario Tumbarello, Annalisa Ciabattini, Francesca Montagnani, Donata Medaglini
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-10 (2023)
Polvere et al. investigate B cell responses after SARS-CoV-2 vaccination in people living with HIV undergoing anti-retroviral therapy. Spike-specific humoral and B cell responses persist for at least six months although a reduced ACE2/RBD binding inh
Externí odkaz:
https://doaj.org/article/73720c84f14541f9b1f7b7ba2b913879
Autor:
Francesca Panza, Fabio Fiorino, Gabiria Pastore, Lia Fiaschi, Mario Tumbarello, Donata Medaglini, Annalisa Ciabattini, Francesca Montagnani, Massimiliano Fabbiani
Publikováno v:
Microorganisms, Vol 11, Iss 10, p 2607 (2023)
Recurrence of coronavirus disease 19 (COVID-19) symptoms and SARS-CoV-2 viral load relapse have been reported in people treated with nirmatrelvir/ritonavir (NM/r). However, little is understood about the etiology of this phenomenon. Our aim was to in
Externí odkaz:
https://doaj.org/article/f34525b84c614771874b7886ef8e2792
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
B cells play a fundamental role in host defenses against viral infections. Profiling the B cell response elicited by SARS-CoV-2 vaccination, including the generation and persistence of antigen-specific memory B cells, is essential for improving the k
Externí odkaz:
https://doaj.org/article/9c2d2f225c864008b0cef836cefa9bad
Autor:
Fabio Fiorino, Annalisa Ciabattini, Anna Sicuranza, Gabiria Pastore, Adele Santoni, Martina Simoncelli, Jacopo Polvere, Sara Galimberti, Claudia Baratè, Vincenzo Sammartano, Francesca Montagnani, Monica Bocchia, Donata Medaglini
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Vaccination against SARS-CoV-2 using mRNA-based vaccines has been highly recommended for fragile subjects, including myelofibrosis patients (MF). Available data on the immune responsiveness of MF patients to mRNA SARS-CoV-2 vaccination, and the impac
Externí odkaz:
https://doaj.org/article/bf5bb9c1fcca49bba08524fa4c9b1a2d
Autor:
Annalisa Ciabattini, Gabiria Pastore, Simone Lucchesi, Giorgio Montesi, Simone Costagli, Jacopo Polvere, Fabio Fiorino, Elena Pettini, Arianna Lippi, Leonardo Ancillotti, Mario Tumbarello, Massimiliano Fabbiani, Francesca Montagnani, Donata Medaglini
Publikováno v:
Cells, Vol 12, Iss 13, p 1706 (2023)
The mRNA vaccines for SARS-CoV-2 have demonstrated efficacy and immunogenicity in the real-world setting. However, most of the research on vaccine immunogenicity has been centered on characterizing the antibody response, with limited exploration into
Externí odkaz:
https://doaj.org/article/de2264b564e24b538d4203fd2b520165
Autor:
Eleonora Vianello, PhD, Patricia Gonzalez-Dias, MSc, Suzanne van Veen, BSc, Carmen G Engele, BSc, Edwin Quinten, BSc, Thomas P Monath, MD, Donata Medaglini, ProfPhD, Francesco Santoro, PhD, Angela Huttner, MD, Sheri Dubey, PhD, Michael Eichberg, PhD, Francis M Ndungu, PhD, Peter G Kremsner, ProfMD, Paulin N Essone, PhD, Selidji Todagbe Agnandji, MD, Claire-Anne Siegrist, ProfMD, Helder I Nakaya, PhD, Tom H M Ottenhoff, ProfMD, Mariëlle C Haks, PhD, Selidij T Agnandij, Rafi Ahmed, Jenna Anderson, Floriane Auderset, Philip Bejon, Luisa Borgianni, Jessica Brosnahan, Annalisa Ciabattini, Olivier Engler, Mariëlle C Haks, Ali M Harandi, Donald G Heppner, Alice Gerlini, Angela Huttner, Peter G Kremsner, Donata Medaglini, Thomas P Monath, Francis M Ndungu, Patricia Njuguna, Tom H M Ottenhoff, David Pejoski, Mark Page, Gianni Pozzi, Francesco Santoro, Claire-Anne Siegrist, Sheri Dubey, Michael Eichberg, Essone P Ndong, Kabwende Lumeka, Helder I Nakaya, Patricia Gonzales Dias Carvalho, Sylvia Rothenberger, Eleonora Vianello, Sravya S Nakka, Suzanne van Veen
Publikováno v:
The Lancet Microbe, Vol 3, Iss 2, Pp e113-e123 (2022)
Summary: Background: A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSVΔG-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and highly protective in a ring vaccination trial. We aimed to ident
Externí odkaz:
https://doaj.org/article/9d0108ac7efd4b3a99b85d9af9182e4b